Filter By Industry
Filter By Tag

Newsroom

Woodland Pharmaceuticals Press releases

1 - 5 of 5 Press Releases

Apr 27, 2017
Woodland Biosciences is a preclinical contract research organization specializing in in vivo oncology and metabolic diseases.

Aug 24, 2015
The partners extend their alliance to now include NASH / Fibrosis / Fatty Liver Disease or Steatosis and their sequelae HCC, or liver cancer to augment their oncology offerings.

Feb 11, 2015
Strategic Alliance in Oncology between Woodland Biosciences and CNBE de l’INRS A Preclinical Oncology Strike Force is Now Available

Sep 18, 2014
Woodland is partnering with PreThera Research of Quebec, Canada to create a "Living Legacy" Viable Tumor Bank to study cancer recurrence and drug resistance with funding from the government. Woodland's new labs will be the center of this activity.

Aug 22, 2012
A full spectrum of preclinical oncology services is enabled by the new strategic partnership of SBH Sciences and Woodland Oncology Services encompassing in vitro assays to in vivo modeling


Woodland Pharmaceuticals RSS Feed